Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sesewanua extract mouthwash is an experimental botanical antibacterial formulation developed by Poltekkes Kemenkes Manado for the treatment and prevention of oral bacterial infections. The active component is an ethanolic extract of Clerodendrum fragrans Wild (sesewanua) leaves, which contains high levels of the flavonoid quercetin (13.47%). The mouthwash works by inhibiting the growth of oral pathogens, most notably Streptococcus mutans, a primary agent in dental plaque and caries formation. Research indicates that a 2% concentration of the extract is particularly effective in reducing oral bacterial loads.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sesewanua extract mouthwash.